Literature DB >> 17289430

Vaccinated students with negative enzyme immunoassay results show positive measles virus-specific antibody levels by immunofluorescence and plaque neutralisation tests.

Annedore Tischer1, Markus Gassner, Jean-Luc Richard, Franziska Suter-Riniker, Annette Mankertz, Ulrich Heininger.   

Abstract

BACKGROUND: The prevalence of measles antibodies was investigated by an enzyme immunoassay (EIA) in students aged 14 every year since 1996 in a Swiss municipality. This region has wide measles vaccine coverage (first dose > or = 95%, second dose > or = 65%) without any reported measles outbreaks since 20 years. In 2003 and 2004, in contrast to previous years, surprisingly many negative results (33% and 54%, respectively) were observed.
OBJECTIVES: To corroborate the measles antibody values by different methods. STUDY
DESIGN: Serum samples from 101 students with known vaccination status were available. Sera with equivocal and negative results obtained by two different EIAs were retested by indirect immunofluorescence test (IFT) and plaque neutralisation test (PNT).
RESULTS: Retesting by IFT showed a positive result in 17/21 sera (81%) and retesting by PNT indicated that 46/49 sera (94%) were positive; the three sera with negative PNT result were from unvaccinated individuals. Only 3/96 vaccinated students showed measles antibodies below the putative protective level of 0.2 IU/ml after retesting by PNT.
CONCLUSIONS: Negative EIA results should be interpreted with caution in a widely vaccinated population without booster by circulation of wild viruses. Retesting by IFT or PNT is recommended.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17289430     DOI: 10.1016/j.jcv.2006.12.017

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  5 in total

1.  Calibration and Evaluation of Quantitative Antibody Titers for Measles Virus by Using the BioPlex 2200.

Authors:  Todd F Hatchette; Heidi Scholz; Shelly Bolotin; Natasha S Crowcroft; Colleen Jackson; Elizabeth McLachlan; Alberto Severini
Journal:  Clin Vaccine Immunol       Date:  2017-01-05

2.  Measles Immunity at 4.5 Years of Age Following Vaccination at 9 and 15-18 Months of Age Among Human Immunodeficiency Virus (HIV)-infected, HIV-exposed-uninfected, and HIV-unexposed Children.

Authors:  Eleonora A M L Mutsaerts; Marta C Nunes; Martijn N van Rijswijk; Kerstin Klipstein-Grobusch; Kennedy Otwombe; Mark F Cotton; Avy Violari; Shabir A Madhi
Journal:  Clin Infect Dis       Date:  2019-08-01       Impact factor: 9.079

3.  Application of a fast and cost-effective 'three-in-one' MMR ELISA as a tool for surveying anti-MMR humoral immunity: the Hungarian experience.

Authors:  K Böröcz; Z Csizmadia; Á Markovics; N Farkas; J Najbauer; T Berki; P Németh
Journal:  Epidemiol Infect       Date:  2020-02-04       Impact factor: 2.451

4.  Measles immunity among pregnant women aged 15-44 years in Namibia, 2008 and 2010.

Authors:  Cristina V Cardemil; Anna Jonas; Anita Beukes; Raydel Anderson; Paul A Rota; Bettina Bankamp; Howard E Gary; Souleymane Sawadogo; Sadhna V Patel; Sikota Zeko; Clementine Muroua; Esegiel Gaeb; Kathleen Wannemuehler; Sue Gerber; James L Goodson
Journal:  Int J Infect Dis       Date:  2016-05-24       Impact factor: 3.623

5.  Highly individual patterns of virus-immune IgG effector responses in humans.

Authors:  Eugenia Corrales-Aguilar; Mirko Trilling; Henrike Reinhard; Valeria Falcone; Albert Zimmermann; Ortwin Adams; Sabine Santibanez; Hartmut Hengel
Journal:  Med Microbiol Immunol       Date:  2016-05-18       Impact factor: 3.402

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.